# Staccato Loxapine Pulmonary Safety in Healthy Volunteers

> **NCT00789360** · PHASE1 · COMPLETED · sponsor: **Alexza Pharmaceuticals, Inc.** · enrollment: 30 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Inhaled Placebo
- **DRUG:** Inhaled Loxapine

## Key facts

- **NCT ID:** NCT00789360
- **Lead sponsor:** Alexza Pharmaceuticals, Inc.
- **Sponsor class:** UNKNOWN
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-11
- **Primary completion:** 2009-04
- **Final completion:** 2009-04
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2019-03-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00789360

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00789360, "Staccato Loxapine Pulmonary Safety in Healthy Volunteers". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00789360. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*